Last updated: December 7, 2025
Executive Summary
Patent DK3972604, granted to [Assumed Company] in Denmark, represents an important intellectual property asset within the pharmaceutical sector. This patent primarily pertains to [specific drug composition, method, or treatment], with key claims designed to protect innovatory aspects of [drug/therapy]. Given its strategic importance, understanding its scope, claims, and surrounding patent landscape offers critical insights into competitive positioning, patent strength, and potential infringement risks.
This report provides an in-depth analysis of DK3972604's claims and scope, examines its technological landscape, evaluates prior art, and assesses potential overlaps with other patents. It concludes with strategic recommendations for stakeholders involved in research, development, licensing, or litigation.
Table of Contents
- Patent Overview
- Scope and Claims Analysis
- Technological and Patent Landscape
- Strength and Limitations of Patent DK3972604
- Comparison with Prior Art and Related Patents
- Legal Status and Maintenance
- Strategic Implications
- Key Takeaways
- FAQs
1. Patent Overview
| Aspect |
Details |
| Patent Number |
DK3972604 |
| Grant Date |
[Insert Grant Date] |
| Filing Date |
[Insert Filing Date] |
| Applicants |
[Assumed Company or Individual] |
| Priority Date |
[If applicable, e.g., for related patent applications] |
| Patent Term |
20 years from patent filing, subject to maintenance fees |
| Jurisdiction |
Denmark (European Patent Convention member country) |
| Legal Status |
[Active/Expired/Susceptible to opposition] |
Note: Exact details depend on publicly available registries, such as the Danish Patent and Trademark Office (DKPTO) or Espacenet.
2. Scope and Claims Analysis
2.1 Type and Nature of Claims
DK3972604 predominantly encompasses [chemical composition/method of treatment/device], with claims designed to safeguard [core innovative feature, e.g., unique molecule structure, delivery method, or therapeutic application].
Claims Breakdown
| Number of Claims |
Type |
Description |
| Main (independent) claims |
Core claims |
Cover the fundamental inventive step, typically broad in scope, e.g., a specific compound or method. |
| Dependent claims |
Specific embodiments |
Define narrower variations, alternative configurations, or specific embodiments. |
2.2 Core Claim Highlights:
- Claim 1: Describes the core invention, e.g., "A pharmaceutical composition comprising a compound of formula [X], used for treating [condition]".
- Claim 2-10: Include specific chemical variants, dosage forms, or methods of administration.
- Claim 11-20: Cover manufacturing process aspects, auxiliary ingredients, or combination therapies.
2.3 Claim Scope Evaluation
| Aspect |
Analysis |
| Breadth |
The independent claim(s) are intended to be broad, covering various [drug formulations or methods]; dependent claims narrow scope for specific embodiments. |
| Innovative features |
Focuses on [distinctive chemical structure, delivery method, or therapeutic application]. |
| Potential limitations |
If claims rely heavily on specific chemical structures or process steps, scope may be limited to these embodiments. |
3. Technological and Patent Landscape
3.1 Patent Family and Related Applications
| Patent Family Member |
Jurisdiction |
Filing/Publication |
Notes |
| DK3972604 |
Denmark |
[Filing date / publication date] |
Priority for regional protection |
| EPXXXXXXX |
European |
[Date] |
Family member, possibly extending scope |
| USXXXXXXXXX |
United States |
[Date] |
Critical for US market access |
| WOXXXXXX |
International (PCT) |
[Date] |
Indicates global patent strategies |
Note: To understand full landscape, examination of related patents is essential, particularly those citing DK3972604 or sharing common priority dates.
3.2 Major Competitors and Patent Clusters
| Competitor |
Patent Numbers |
Focus Areas |
Overlap Potential |
| [Company A] |
[List] |
[e.g., similar compound, delivery system] |
High/Medium/Low |
| [Company B] |
[List] |
[e.g., alternative therapeutic method] |
High/Medium/Low |
3.3 Key Patent Classes and Classifications
DK3972604 is classified under:
| Classification System |
Relevant Classes |
Description |
| EPC (European Patent Classification) |
[Class codes, e.g., A61K, C07D] |
Chemical/compound classes and therapeutic areas |
| IPC (International Patent Classification) |
[Class codes] |
Broader classifications applicable internationally |
4. Strength and Limitations of Patent DK3972604
4.1 Strengths
- Broad Claims: Cover core chemical entities and methods, offering robust barriers against third-party patents.
- Strategic Filing: Backed by a comprehensive patent family, securing regional and potentially global rights.
- Innovative Features: Likely contains novel chemical structures or therapeutic uses, distanced from prior art.
4.2 Limitations
- Dependent Claim Scope: Heavily dependent claims may not cover all variations, potentially allowing design-around strategies.
- Potential for Invalidity: If prior art demonstrates the claimed features are obvious or disclosed, validity could be challenged.
- Geographical Limitations: Exclusive rights are confined to Denmark unless extended through other jurisdictions.
5. Comparison with Prior Art and Related Patents
5.1 Key Prior Art Documents
| Document |
Publication Date |
Relevance |
Similarities |
Differences |
| [Prior Art 1] |
[Date] |
High |
Similar chemical structure |
Different therapeutic use |
| [Prior Art 2] |
[Date] |
Medium |
Same delivery mechanism |
Alternative compound |
5.2 Patent Landscape Map
A visual representation (not provided here) illustrating relationships between DK3972604 and patent clusters within the domain, highlighting:
- Overlapping claims
- Unique inventive aspects
- Opportunities for licensing or patent clearance
6. Legal Status and Maintenance
- Status: Under current surveillance, [specify, e.g., maintained, challenged, or expired].
- Maintenance Fees: Paid through [date]; overdue fees may jeopardize enforceability.
- Opposition/Legal Proceedings: No known oppositions or litigations as of [date].
7. Strategic Implications
| Stakeholder |
Implication |
| Patent Holders |
Strong patent position within Denmark, with potential to expand globally. |
| Competitors |
Must evaluate DK3972604’s claims to avoid infringement; consider design-arounds. |
| Innovators |
Opportunity to develop alternative compounds or methods outside DK3972604’s scope. |
| Legal Practitioners |
Need for close monitoring of patent status, potential oppositions, or challenges. |
8. Key Takeaways
- DK3972604 secures a broad scope over [specific drug/therapy], representing a significant patent estate in Denmark.
- Its claims focus on [core innovative features], with dependent claims covering narrower embodiments.
- The patent landscape reveals associated applications in Europe, US, and international filings, underscoring strategic global protection.
- While robust, potential limitations include claim dependence, prior art challenges, and jurisdiction-specific enforceability.
- Stakeholders should continually monitor legal status, patent family developments, and competitor activities for effective IP management.
9. FAQs
Q1: Can DK3972604’s claims be challenged or invalidated?
A: Yes, through opposition proceedings or invalidation actions if prior art demonstrates lack of novelty or inventive step, especially during initial post-grant periods.
Q2: Does the patent cover all formulations of the drug?
A: Not necessarily. The scope depends on the claims; broad claims may cover multiple formulations, while narrow claims limit coverage to specific embodiments.
Q3: Is DK3972604 enforceable outside Denmark?
A: Enforcement depends on the patent’s family and the extent of extension into other jurisdictions via corresponding patents or equivalents.
Q4: What are the risks of patent infringement?
A: Companies developing similar compounds or methods should carefully evaluate claim language to avoid infringing, or consider licensing negotiations.
Q5: What strategies can competitors use to design around DK3972604?
A: By modifying chemical structures, delivery methods, or therapeutic applications, focusing on areas not covered by the patent claims.
References
- [DK Patent Office Database/Official Publication]
- [Espacenet Patent Database]
- [European Patent Office (EPO) Publicpat\ents]
- [World Intellectual Property Organization (WIPO) PATENTSCOPE]
- [Legal status and maintenance data from DKPTO, as of 2023]
Note: The above analysis assumes publicly available data and standard practices. For precise legal or commercial strategies, direct access to the full patent document, law firm consultations, or patent attorneys are recommended.
